<SEC-DOCUMENT>0001140361-25-031008.txt : 20250814
<SEC-HEADER>0001140361-25-031008.hdr.sgml : 20250814
<ACCEPTANCE-DATETIME>20250814062615
ACCESSION NUMBER:		0001140361-25-031008
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250813
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250814
DATE AS OF CHANGE:		20250814

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aquestive Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001398733
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				208623253
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38599
		FILM NUMBER:		251214098

	BUSINESS ADDRESS:	
		STREET 1:		30 TECHNOLOGY DRIVE
		CITY:			WARREN
		STATE:			NJ
		ZIP:			07059
		BUSINESS PHONE:		908-941-1900

	MAIL ADDRESS:	
		STREET 1:		30 TECHNOLOGY DRIVE
		CITY:			WARREN
		STATE:			NJ
		ZIP:			07059

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MonoSol Rx, Inc.
		DATE OF NAME CHANGE:	20070507
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ef20053941_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2025" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:aqst="http://aquestive.com/20250813" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.7.1.5324
         Copyright 1995 - 2025 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_8590a8519b624df2a6a03db9b98bb2c7" contextRef="c20250813to20250813" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_14e1fd433a464d3cb893b0f1ed386362" contextRef="c20250813to20250813">0001398733</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_d027e847def247de9a0af51b729ac075" contextRef="c20250813to20250813">NASDAQ</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="aqst-20250813.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20250813to20250813"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-13</xbrli:startDate><xbrli:endDate>2025-08-13</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
<div style="line-height: initial;">
  <div><span style="font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
    <div>
      <div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, DC 20549</div>

        <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
          </span></div>

      </div>

      <div style="text-align: left; font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_550d97bc38f54e7ca5c869efc3614039" contextRef="c20250813to20250813">8-K</ix:nonNumeric></div>

        <div style="font-size: 10pt;">&#160;</div>

        <div style="font-size: 10pt;">
          <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      </div>

      <div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

        <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
          </span></div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PURSUANT TO SECTION 13 OR 15(d) OF THE</div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SECURITIES EXCHANGE ACT OF 1934</div>

        <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
          </span></div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_f11edf6e313045d3b4722310ba864d90" contextRef="c20250813to20250813" format="ixt:date-monthname-day-year-en">August 13, 2025</ix:nonNumeric></div>

      </div>

      <div style="text-align: left; font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_64310fc431f54fa7910dc26f82ebaa45" contextRef="c20250813to20250813">Aquestive Therapeutics, Inc.</ix:nonNumeric><br/>
        </div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Exact name of Registrant as specified in its charter)</div>

      </div>

      <div style="text-align: left; font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 33%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_3c0055d856384b7eabf36d659da50a4d" contextRef="c20250813to20250813" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 34%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_575cef317a76469ea5f80274b5d7b236" contextRef="c20250813to20250813">001-38599</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 33%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_a90b952f0cd940e08515aa72e9658194" contextRef="c20250813to20250813">82-3827296</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(State or Other Jurisdiction of Incorporation or Organization)</div>
            </td>

    <td style="width: 34%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Commission File Number)</div>
            </td>

    <td style="width: 33%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(I.R.S. Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div>
        <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
          </span></div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_007234e81b47455c8455658b73ecf4ad" contextRef="c20250813to20250813">30 Technology Drive</ix:nonNumeric><br/>
        </div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_36298e7c34d3483880a47a7bb7772ffb" contextRef="c20250813to20250813">Warren</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_1d2011a76bed401889accda3a18e612b" contextRef="c20250813to20250813">NJ</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_71df0b368b824a799d18afcbf84ae67b" contextRef="c20250813to20250813">07059</ix:nonNumeric></div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
          <div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_e2e7c5d3cbe44158b0b0b0f371627afc" contextRef="c20250813to20250813">908</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_cf1c3483419e4cf68cef1ceeca09e194" contextRef="c20250813to20250813">941-1900</ix:nonNumeric></div>

          </div>

        </div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant&#8217;s Principal Executive Offices)</div>

        <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"> </span><span style="font-size: 10pt;"><br/>
          </span></div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Not Applicable</div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Former name or former address, if changed since last report)</div>

      </div>

      <div style="text-align: left; font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
          provisions:</div>

        <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
          </span></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_7310a4f97871433aa246fe451894b4a0" contextRef="c20250813to20250813" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_62dfb1293f5f4dd59963bc3be1bd8a38" contextRef="c20250813to20250813" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_7cecc81e06f94dfeb7fce099cf2c0ad5" contextRef="c20250813to20250813" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
            </td>

  </tr>


</table>
      <div style="text-align: left; text-indent: -9pt; margin-left: 9pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_72069f83647447788d22d00f003315b2" contextRef="c20250813to20250813" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 40.14%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Title of each class</div>
            </td>

    <td style="width: 18.95%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Trading Symbol(s)</div>
            </td>

    <td style="width: 40.91%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Name of each exchange on which registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 40.14%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_da0e9b2ba3aa447d8dd4310cce79d21a" contextRef="c20250813to20250813">Common Stock, par value $0.001 per share</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 18.95%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_e56dc2b4aec343d1be32a0b17b3153a2" contextRef="c20250813to20250813">AQST</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 40.91%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="-sec-ix-hidden:Fact_d027e847def247de9a0af51b729ac075">Nasdaq Global Market</span><br/>
              </div>
            </td>

  </tr>


</table>
      <div>
        <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
          </span></div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8201;230.405 of this chapter) or Rule
          12b-2 of the Securities Exchange Act of 1934 (&#167;&#8201;240.12b-2 of this chapter).</div>

        <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
          </span></div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_6f78de1a15914500a55078a0d69aeb65" contextRef="c20250813to20250813" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

        <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
          </span></div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
          financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

      </div>

      <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: left;">
<div><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span></div>

        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 1.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Entry into a Material Definitive Agreement.</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div>
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On August 13, 2025, Aquestive Therapeutics, Inc. (the &#8220;Company&#8221;) entered into a purchase and sale agreement (the &#8220;Purchase Agreement&#8221;) with funds
          managed by RTW Investments LP (the &#8220;Purchaser&#8221;). Under the terms of the Purchase Agreement, in exchange for the Purchaser&#8217;s payment to the Company of a purchase price of $75 million (the &#8220;Purchase Price&#8221;), upon approval of Anaphylm by the FDA by
          a specified date, the refinancing of the Company&#8217;s existing 13.5% Senior Secured Notes and certain other customary conditions, the Company agreed to a true sale of assigned interests to the Purchaser, including a right for the Purchaser to tiered
          revenue share payments ranging from 7.5% to 1.0% of Net Sales (as defined in the Purchase Agreement) (and 9.5% for the subsequent calendar year period if Net Sales do not achieve specified level in a calendar year period beginning in 2027) in the
          United States. Revenue share payments commence in the first fiscal quarter in which the first commercial sale of Anaphylm in the United States after the closing of the transaction. Revenue share payments will cease upon the Purchaser&#8217;s receipt of
          $187.5 million by December 31, 2035 or $225 million thereafter. The Purchase Agreement contains customary affirmative and negative covenants, including covenants that limit or restrict the Company&#8217;s ability to, among other things, incur
          indebtedness(which restrictions are eliminated after the achievement by the Purchaser of a specified return on its investment), and other provisions customary for transactions of this nature, in each case subject to certain exceptions set forth
          in the Purchase Agreement.</div>

        <div style="font-size: 10pt;"><br/>
        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 7.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Regulation FD Disclosure.</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="font-size: 10pt;">
        <div style="text-align: justify; text-indent: 36pt; color: rgb(33, 37, 41); font-family: 'Times New Roman';">On August 14, 2025, the Company issued a press release announcing the Purchase Agreement described above. A copy of the press release is
          attached as Exhibit 99.1 and incorporated herein by reference.</div>

      </div>

      <div>
        <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #212529;"> </span><span style="font-size: 10pt;"><br/>
          </span></div>

      </div>

      <div style="font-size: 10pt;">
        <div style="text-align: justify; text-indent: 36pt; color: rgb(33, 37, 41); font-family: 'Times New Roman';">The information contained under Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.1), shall not be deemed &#8220;filed&#8221; for
          purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of
          1933, as amended, or the Exchange Act except as may be expressly set forth by specific reference in such filing.</div>

      </div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Forward-Looking Statements</div>

      <div style="text-align: justify;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Statements contained in this report regarding matters that are not historical facts are &#8220;forward-looking statements&#8221; within the meaning of the Private Securities
        Litigation Reform Act of 1995, including, without limitation, statements about the Company&#8217;s expectations with respect to the description of the Purchase Agreement and the transactions contemplated thereby. Because such statements are subject to
        risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as &#8220;believes,&#8221; &#8220;anticipates,&#8221; &#8220;plans,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;will,&#8221; &#8220;goal,&#8221; &#8220;potential&#8221; and similar
        expressions are intended to identify forward-looking statements. These forward-looking statements are based upon the Company&#8217;s current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results and
        the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, risks and uncertainties associated with approval of Anaphylm
        by the FDA, refinancing the Company&#8217;s existing debt and the satisfaction of customary closing conditions. Additional factors that could cause actual results to differ materially from those stated or implied by the Company&#8217;s forward-looking
        statements are disclosed in the Company&#8217;s filings with the Securities and Exchange Commission, including in the section captioned &#8220;Risk Factors&#8221; in the Company&#8217;s annual report on Form 10-K for the fiscal year ended December 31, 2024. All
        forward-looking statements contained in this report speak only as of the date on which they were made. The Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which
        they were made. These forward-looking statements should not be relied upon as representing the Company&#8217;s views as of any date subsequent to the date of this report.</div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">Financial Statements and Exhibits</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(d) Exhibits.</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 17%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Exhibit Number</div>
            </td>

    <td style="width: 1%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 82%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Description</div>
            </td>

  </tr>

  <tr>

    <td style="width: 17%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 1%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 82%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 17%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';"><a href="ef20053941_ex99-1.htm">99.1</a></div>
            </td>

    <td style="width: 1%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 82%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Press Release of the Company issued on August 14, 2025</div>
            </td>

  </tr>


</table>
      <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

        <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
          </span></div>

      </div>

      <div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the
          undersigned hereunto duly authorized.</div>

        <div style="text-align: justify;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
          </span></div>

      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Dated: August 14, 2025</div>
            </td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Aquestive Therapeutics, Inc.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: middle; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: middle; font-size: 10pt;">&#160;</td>

    <td style="width: 50%; vertical-align: middle; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">By:</div>
            </td>

    <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">/s/ A. Ernest Toth, Jr.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Name: A. Ernest Toth, Jr.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Title: Chief Financial Officer</div>
            </td>

  </tr>


</table>
      <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left;">
<div><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span></div>

        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    </div>

  </div>

  <div><span style="font-size: 10pt;"> </span></div>

</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ef20053941_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.7.1.5324
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;">
  </font>
  <div>
    <div style="text-align: right;">
      <hr noshade="noshade" style="height: 4px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); margin-left: auto; margin-right: auto; border: medium none;"></div>
    <div style="text-align: right;"><font style="font-weight: bold; font-size: 10pt;">Exhibit 99.1</font><font style="font-size: 10pt;"><br>
      </font></div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z92150b66078f4843b4ae75598ac8a727">

          <tr>
            <td style="width: 50%; font-size: 10pt;">
              <div>&#160;</div>
            </td>
            <td style="width: 50%; text-align: right; font-size: 10pt;"><img src="image.jpg"></td>
          </tr>

      </table>
    </div>
    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Aquestive Therapeutics Announces $75M Strategic Funding Agreement with RTW to Support the Potential Launch of Anaphylm&#8482;
      (epinephrine) Sublingual Film</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z69167153be514183a02836d898f9a882" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right; font-size: 10pt;">
              <div style="text-align: left; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">Anaphylm launch funding of $75 million committed by RTW, subject to FDA approval of Anaphylm and other conditions</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zc1f2c951e7aa4180864977367dbba9da" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right; font-size: 10pt;">
              <div style="text-align: left; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">Strategic financing will further strengthen the Company&#8217;s balance sheet in advance of potential commercialization of Anaphylm
                for the emergency treatment of allergic reactions, including anaphylaxis</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WARREN, N.J., August 14, 2025</font><font style="font-size: 10pt;"> &#8211; Aquestive Therapeutics, Inc. (NASDAQ: AQST) (&#8220;Aquestive&#8221; or the &#8220;Company&#8221;), a pharmaceutical company advancing medicines to bring meaningful improvement to patients&#8217; lives through innovative science and delivery technologies, today
        announced a $75 million strategic funding agreement with funds managed by RTW Investments, LP&#160;(&#8220;RTW&#8221;), subject to United States Food and Drug Administration (FDA) approval of Anaphylm&#8482; (epinephrine) Sublingual Film and other conditions.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8220;This financing provides critical capital that will support Aquestive Therapeutics through 2027, enabling us to successfully bring
      Anaphylm to market, if approved by the FDA, and deliver a new treatment option for patients in need,&#8221; said Dan Barber, Chief Executive Officer of Aquestive. &#8220;We continue to believe Anaphylm, potentially the first and only oral rescue medication for
      the treatment of severe allergic reactions, including anaphylaxis, can transform how patients carry and access their rescue medication. We are excited to partner with RTW to bring this important medication to patients, if approved by the FDA.&#8221;</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8220;We are excited to support Aquestive, and today&#8217;s investment reflects our belief in the commercial prospects of Anaphylm as a rescue
      treatment for patients experiencing a severe allergic reaction, including anaphylaxis,&#8221; said&#160;Roderick Wong, MD, Managing Partner and Chief Investment Officer of RTW Investments, LP. &#8220;We remain committed to helping life science companies bring
      meaningful innovations, like Anaphylm, to patients, caregivers, and healthcare providers.&#8221;</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The commercial launch financing will become available upon approval of Anaphylm by the FDA, and satisfaction of certain refinancing and
      other customary conditions related to the Company&#8217;s existing debt. Under the terms of the agreement, RTW will receive a tiered single digit percentage of annual net sales of Anaphylm in the U.S. for the treatment of type I allergic reactions
      (including anaphylaxis), subject to a cap.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Cantor Fitzgerald &amp; Co acted as exclusive financial advisor to Aquestive on the royalty financing.</div>
    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"> <font style="font-size: 10pt;"><br>
      </font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">

      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      <div id="BRPFPageHeader">
        <div>
          <div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50.00%;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 50%; text-align: right;"><img src="image.jpg"></td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    </div>
    <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">About Anaphylm&#8482; (epinephrine) Sublingual Film</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font><font style="font-size: 10pt;">Anaphylm&#8482; (epinephrine) Sublingual Film is a polymer matrix-based epinephrine prodrug product candidate. Anaphylm is similar in size to a postage stamp, weighs less than an ounce, and begins to dissolve on
        contact. No water or swallowing is required for administration. The packaging for Anaphylm is thinner and smaller than an average credit card, can be carried in a pocket, and is designed to withstand weather excursions such as exposure to rain
        and/or sunlight. The Anaphylm trade name for AQST-109 has been conditionally approved by the FDA. Final approval of the Anaphylm proprietary name is conditioned on FDA approval of the product candidate.</font></div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About Aquestive Therapeutics</div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Aquestive is a pharmaceutical company advancing medicines to bring meaningful improvement to patients&#8217; lives through innovative science
      and delivery technologies. We are developing orally administered products to deliver complex molecules, providing novel alternatives to invasive and inconvenient standard of care therapies. Aquestive has four commercialized products marketed by its
      licensees in the U.S. and around the world, and is the exclusive manufacturer of these licensed products. The Company also collaborates with pharmaceutical companies to bring new molecules to market using proprietary, best-in-class technologies, like
      PharmFilm&#174;, and has proven drug development and commercialization capabilities. Aquestive is advancing a late-stage proprietary product candidate for the treatment of severe allergic reactions, including anaphylaxis, and an earlier stage epinephrine
      prodrug topical gel product candidate for possible various dermatology conditions, including alopecia areata. For more information, visit Aquestive.com and follow us on LinkedIn.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About&#160;RTW Investments, LP</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">RTW Investments, LP&#160;is a&#160;New York-based, global, full life-cycle investment firm that focuses on identifying transformational and disruptive innovations across
      the biopharmaceutical and medical technologies sectors. As a leading partner of industry and academia, RTW combines deep scientific expertise with a solution-oriented investment approach to advance emerging medical therapies by building and
      supporting the companies and/or academics developing them. For further information about RTW, please visit&#160;<font style="font-family: 'Times New Roman';">www.rtwfunds.com</font>.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Forward-Looking Statement</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Certain statements in this press release include &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995. Words
      such as &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; or the negative of those terms, and similar expressions, are intended to identify forward-looking statements. These forward-looking statements include, but are
      not limited to, statements regarding the advancement and related timing of our product candidate Anaphylm&#8482; (epinephrine) Sublingual Film through clinical development and approval by the FDA; the expected plans for regulatory approval and
      commercialization of Anaphylm in markets outside of the United States, if approved by the applicable regulatory authorities; the potential for Anaphylm to be the first and only orally delivered epinephrine product and its ability change the standard
      of care; the advancement of the Company&#8217;s product candidate AQST-108 through clinical development and approval by the FDA for possible various dermatology conditions including alopecia areata; the potential benefits our products and product
      candidates could bring to patients; and business strategies, market opportunities, and other statements that are not historical facts.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">

      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      <div id="BRPFPageHeader">
        <div>
          <div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50.00%;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 50%; text-align: right;"><img src="image.jpg"></td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">These forward-looking statements are based on our current expectations and beliefs and are subject to a number of risks and uncertainties
      that could cause actual results to differ materially from those described in the forward-looking statements. Such risks and uncertainties include, but are not limited to, risks associated with our development work, including any delays or changes to
      the timing, cost and success of our product development activities and clinical trials and plans, including those relating to Anaphylm and AQST-108; risk of delays in advancement of the regulatory approval process through the FDA of our product
      candidates, including with respect to the approval of our filed NDA for Anaphylm, or the failure to receive FDA approval at all for any of our product candidates, including Anaphylm and AQST-108; risk of the Company&#8217;s ability to generate sufficient
      clinical data for approval of our product candidates, including with respect to our pharmacokinetic and pharmacodynamic comparability submission for FDA approval of Anaphylm; risk of the Company&#8217;s ability to address the FDA&#8217;s comments on the
      Company&#8217;s clinical trials and other concerns identified in the FDA&#8217;s Type C meeting minutes and filing review letter for Anaphylm, including the risk that the FDA may require additional clinical studies for approval of Anaphylm; risk that the FDA may
      require that an Advisory Committee be required for the approval of Anaphylm and that the Company is able to address any concerns raised by such Advisory Committee or the FDA after review of the advice from the Advisory Committee; risk of delays in
      advancement of the regulatory approval process outside the U.S. of our product candidates, including Anaphylm in Canada and the European Union; risk of the success of any competing products, including generics; risks and uncertainties inherent in
      commercializing a new product (including technology risks, financial risks, market risks and implementation risks and regulatory limitations); risk of sufficient capital and cash resources, including sufficient access to available debt and equity
      financing, including under our ATM facility, and revenues from operations, to satisfy all of our short-term and longer-term liquidity and cash requirements and other cash needs, at the times and in the amounts needed, including to fund
      commercialization activities relating to fund future clinical development and commercial activities for our product candidates, including Anaphylm and AQST-108, should these product candidates be approved by the FDA, Health Canada and EMA; risk of
      eroding market share for Suboxone&#174; and risk as a sunsetting product, which accounts for the substantial part of our current operating revenue; risk of default of our debt instruments; risks related to the outsourcing of certain sales, marketing and
      other operational and staff functions to third parties; risk of the rate and degree of market acceptance in and outside of the U.S. of Anaphylm and our other product candidates, should these product candidates be approved by the FDA, Health Canada
      and EMA, and for our licensed products in the U.S. and abroad; risk of the size and growth of our product markets; risk of compliance with all FDA and other governmental and customer requirements for our manufacturing facilities; risks associated
      with intellectual property rights and infringement claims relating to our products; risk that our patent applications for our product candidates, including for Anaphylm, will not be timely issued, or issued at all, by the U.S. Patent and Trademark
      Office (USPTO); risk of unexpected patent developments; risk of legislation and regulatory actions and changes in laws or regulations affecting our business including relating to our products and products candidates and product pricing, reimbursement
      or access therefor; risk of loss of significant customers; risks related to claims and legal proceedings against Aquestive including patent infringement, securities, business torts, investigative, product safety or efficacy and antitrust litigation
      matters; risk of product recalls and withdrawals; risks related to any disruptions in our information technology networks and systems, including the impact of cybersecurity attacks; risk of increased cybersecurity attacks and data accessibility
      disruptions due to remote working arrangements; risk of adverse developments affecting the financial services industry; risks related to inflation and rising interest rates; risks related to the impact of the COVID-19 global pandemic and other
      pandemic diseases on our business; risks and uncertainties related to general economic, political (including the Ukraine and Israel wars and other acts of war and terrorism), business, industry, regulatory, financial and market conditions; risks
      related to uncertainties about U.S. government initiatives and their impact on our business, including imposition of tariffs and other trade restrictions; and other unusual items; and other uncertainties affecting us including those described in the
      &#8220;Risk Factors&#8221; section and in other sections included in the Company&#8217;s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K filed with the U.S. Securities and Exchange Commission. Given those uncertainties, you
      should not place undue reliance on these forward-looking statements, which speak only as of the date made. All subsequent forward-looking statements attributable to the Company or any person acting on its behalf are expressly qualified in their
      entirety by this cautionary statement. The Company assumes no obligation to update forward-looking statements or outlook or guidance after the date of this press release whether as a result of new information, future events or otherwise, except as
      may be required by applicable law.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">

      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      <div id="BRPFPageHeader">
        <div>
          <div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50.00%;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 50%; text-align: right;"><img src="image.jpg"></td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">PharmFilm&#174; and the Aquestive logo are registered trademarks of Aquestive Therapeutics, Inc. All other registered trademarks referenced
      herein are the property of their respective owners.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Investor Contact:</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Brian Korb</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">astr partners</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><u>brian.korb@astrpartners.com</u></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <hr align="center" noshade="noshade" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
      <font style="font-size: 10pt;"><br>
      </font></div>
    <div style="font-size: 10pt;"><br>
    </div>
  </div>
  <font style="font-size: 10pt;">
  </font>
  <div style="width: 100%;" class="BRPFPageFooter"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>aqst-20250813.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.7.1.5324 Broadridge-->
<xs:schema targetNamespace="http://aquestive.com/20250813" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:aqst="http://aquestive.com/20250813" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:srt-types="http://fasb.org/srt-types/2025">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="aqst-20250813_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="aqst-20250813_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://aquestive.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2025" schemaLocation="https://xbrl.sec.gov/exch/2025/exch-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2025" schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2025" schemaLocation="https://xbrl.sec.gov/sic/2025/sic-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2025" schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>aqst-20250813_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.7.1.5324 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>aqst-20250813_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.7.1.5324 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://aquestive.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="aqst-20250813.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://aquestive.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image.jpg
<TEXT>
begin 644 image.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  <%!08%! <&!08(!P<("A$+"@D)
M"A4/$ P1&!4:&1@5&!<;'B<A&QTE'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_
MVP!# 0<(" H)"A0+"Q0J'!@<*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1"  K (<# 2(  A$! Q$!_\0
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MLWVGZ7'9:Q,(+:."_$ES [?ZOSDQP"< XZ9KUC1YK^XTJ&35K=+:[.=\2-N
MYXY^E>=>'OA?KGAZ[L;>#7M,GTJSF5E$ND1FZ>-6SL,OZ;NM>HCI0 M%%% !
M01FBB@# \1>!_#OBH ZYI<5Q(HPLPRD@'^\N#67HGPF\(>']4BU'3].?[5 V
MZ*26=WV'U )Q79T5JJU11Y5)V(=.#?,UJ)@48%+1618F!2,BNI5@&4]0>0:=
H10 @15 "@ #H!VHP*6B@!,"C I:* $P*,"EHH 3 I:** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 13, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 13,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38599<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Aquestive Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001398733<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-3827296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">30 Technology Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Warren<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">908<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">941-1900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AQST<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ef20053941_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>aqst-20250813.xsd</File>
    <File>aqst-20250813_lab.xml</File>
    <File>aqst-20250813_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ef20053941_8k.htm">ef20053941_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ef20053941_8k.htm": {
   "nsprefix": "aqst",
   "nsuri": "http://aquestive.com/20250813",
   "dts": {
    "schema": {
     "local": [
      "aqst-20250813.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/exch/2025/exch-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/sic/2025/sic-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "aqst-20250813_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aqst-20250813_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ef20053941_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://aquestive.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20250813to20250813",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20053941_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20250813to20250813",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20053941_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://aquestive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001140361-25-031008-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-031008-xbrl.zip
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MA[FL"/&NJ6!-<:C9[C2[[=8V#1NR1!&N,8F";TMXR:G=Z_7\/'J \D3$D?I
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M7/+<7MJE7UK"$3\@?GB^CX@_XH?:G_X'4$L#!!0    ( $8S#EN<0:=[_!<
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M81E X#G.SJ)Y7S-:UHIC*?+NI?(6)><AN =77V,4\-)$*1E/<CE!V0;M,)@
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MC'2!%.HI@9S70$..)[O@RS"Y5Q%)$G!@E9L<Y]F(>#A/>!@4[ \(T DOR#D
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MQ!$HHZB8 "T W$E2:(W#!);8UUO/0.VH; >@1M:Z"$ !U85?I1!:,6JULY*
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MZP:*>E77= 0MF4\?T)<3\X?P1<O_!U!+ 0(4 Q0    ( $8S#EO,G!JU1@,
M #P/   1              "  0    !A<7-T+3(P,C4P.#$S+GAS9%!+ 0(4
M Q0    ( $8S#EM[SRL(>P@  #!6   5              "  74#  !A<7-T
M+3(P,C4P.#$S7VQA8BYX;6Q02P$"% ,4    " !&,PY;=X2B+-T%  #S/@
M%0              @ $C#   87%S="TR,#(U,#@Q,U]P<F4N>&UL4$L! A0#
M%     @ 1C,.6YQ!IWO\%P  6)   !$              ( !,Q(  &5F,C P
M-3,Y-#%?.&LN:'1M4$L! A0#%     @ 1C,.6T#Y]=B\%@  <5D  !4
M         ( !7BH  &5F,C P-3,Y-#%?97@Y.2TQ+FAT;5!+!08     !0 %
+ $<!  !-00     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>ef20053941_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="aqst-20250813.xsd" xlink:type="simple"/>
    <context id="c20250813to20250813">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <startDate>2025-08-13</startDate>
            <endDate>2025-08-13</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20250813to20250813"
      id="Fact_8590a8519b624df2a6a03db9b98bb2c7">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20250813to20250813"
      id="Fact_14e1fd433a464d3cb893b0f1ed386362">0001398733</dei:EntityCentralIndexKey>
    <dei:SecurityExchangeName
      contextRef="c20250813to20250813"
      id="Fact_d027e847def247de9a0af51b729ac075">NASDAQ</dei:SecurityExchangeName>
    <dei:DocumentType
      contextRef="c20250813to20250813"
      id="Fact_550d97bc38f54e7ca5c869efc3614039">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20250813to20250813"
      id="Fact_f11edf6e313045d3b4722310ba864d90">2025-08-13</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20250813to20250813"
      id="Fact_64310fc431f54fa7910dc26f82ebaa45">Aquestive Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20250813to20250813"
      id="Fact_3c0055d856384b7eabf36d659da50a4d">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20250813to20250813"
      id="Fact_575cef317a76469ea5f80274b5d7b236">001-38599</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20250813to20250813"
      id="Fact_a90b952f0cd940e08515aa72e9658194">82-3827296</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20250813to20250813"
      id="Fact_007234e81b47455c8455658b73ecf4ad">30 Technology Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20250813to20250813"
      id="Fact_36298e7c34d3483880a47a7bb7772ffb">Warren</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20250813to20250813"
      id="Fact_1d2011a76bed401889accda3a18e612b">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20250813to20250813"
      id="Fact_71df0b368b824a799d18afcbf84ae67b">07059</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20250813to20250813"
      id="Fact_e2e7c5d3cbe44158b0b0b0f371627afc">908</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20250813to20250813"
      id="Fact_cf1c3483419e4cf68cef1ceeca09e194">941-1900</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20250813to20250813"
      id="Fact_7310a4f97871433aa246fe451894b4a0">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20250813to20250813"
      id="Fact_62dfb1293f5f4dd59963bc3be1bd8a38">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20250813to20250813"
      id="Fact_7cecc81e06f94dfeb7fce099cf2c0ad5">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20250813to20250813"
      id="Fact_72069f83647447788d22d00f003315b2">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20250813to20250813"
      id="Fact_da0e9b2ba3aa447d8dd4310cce79d21a">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20250813to20250813"
      id="Fact_e56dc2b4aec343d1be32a0b17b3153a2">AQST</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20250813to20250813"
      id="Fact_6f78de1a15914500a55078a0d69aeb65">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
